Brian Burgess, DO, PhD | Authors

Articles

Challenges With Targeted Therapies in Ovarian Cancer

May 18, 2018

Brian Burgess, DO, PhD, a first-year fellow at the University of Kentucky, discusses the biggest challenge with targeted therapies in ovarian cancer. PARP resistance has become a huge barrier in this treatment paradigm.